Tasigna

In the US, Tasigna (nilotinib systemic) is a member of the drug class BCR-ABL tyrosine kinase inhibitors and is used to treat Chronic Myelogenous Leukemia.

US matches:

• Tasigna

UK matches:

• Tasigna 200 mg hard capsules
• Tasigna 200 mg hard capsules (SPC)

Ingredient matches for Tasigna

Nilotinib

Nilotinib is reported as an ingredient of Tasigna in the following countries:

• Slovenia

Nilotinib hydrochloride (a derivative of Nilotinib) is reported as an ingredient of Tasigna in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Croatia (Hrvatska)


• Denmark


• Germany


• Indonesia


• Japan


• Netherlands


• New Zealand


• Norway


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.